NCT02712424View on ClinicalTrials.gov

DAR-901 TB Booster Vaccine to Prevent TB in Adolescents

PHASE2CompletedINTERVENTIONAL
Enrollment

625

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 1, 2020

Study Completion Date

February 1, 2020

Conditions
Tuberculosis
Interventions
BIOLOGICAL

DAR-901

BIOLOGICAL

Sterile saline placebo

Trial Locations (1)

Unknown

Muhimbili University of Health and Allied Sciences, Dar es Salaam

All Listed Sponsors
collaborator

Muhimbili University of Health and Allied Sciences

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT02712424 - DAR-901 TB Booster Vaccine to Prevent TB in Adolescents | Biotech Hunter | Biotech Hunter